Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS)

CNY 11.25

(2.18%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.61 Billion 1.47 Billion 1.21 Billion 641.25 Million 488.04 Million 282.36 Million
Total Current Assets 931.18 Million 935.89 Million 874.97 Million 362.75 Million 249.68 Million 77.21 Million
Cash And Short Term Investments 362.07 Million 359.23 Million 454.36 Million 113.98 Million 95.61 Million 11.46 Million
Cash and Cash Equivalents 362.07 Million 269.23 Million 254.36 Million 103.98 Million 95.61 Million 11.46 Million
Short Term Investments 100.00 90 Million 200 Million 10 Million - -
Net Receivables 491.54 Million 497.82 Million 345.9 Million 198.73 Million 120.12 Million 43.11 Million
Inventory 72.11 Million 78.52 Million 74.5 Million 45.99 Million 33.93 Million 22.59 Million
Other Current Assets 164.88 Thousand 318.68 Thousand 205.43 Thousand 4.04 Million 3272.05 42.84 Thousand
Total Non-Current Assets 681.41 Million 542.97 Million 336.9 Million 278.49 Million 238.36 Million 205.15 Million
Net PPE 425.87 Million 378.35 Million 259.27 Million 240.38 Million 198.61 Million 190.27 Million
Good Will And Intangible Assets 202.91 Million 139 Million 37.99 Million 29.76 Million 28.38 Million 13.1 Million
Good Will - - - - - -
Intangible Assets 202.91 Million 139 Million 37.99 Million 29.76 Million 28.38 Million 13.1 Million
Long-Term Investments 9.66 Million 1.00 10.7 Million - - 724.91 Thousand
Tax Assets 14.07 Million 9.55 Million 7.1 Million - - 33.1 Thousand
Other Non Current Assets 28.88 Million 16.06 Million 21.81 Million 8.34 Million 11.35 Million 1.02 Million
Other Assets 1.00 1.00 - - - -
Total Liabilities 681.84 Million 587.02 Million 367.22 Million 264.28 Million 147.2 Million 87.88 Million
Total Current Liabilities 476.21 Million 525.22 Million 341.66 Million 239.82 Million 137.99 Million 85.21 Million
Account Payables 40.05 Million 80.68 Million 34.27 Million 33.08 Million 13.55 Million 6.34 Million
Tax Payables 6.74 Million 13.66 Million 8.34 Million 1.82 Million 1.38 Million 355.67 Thousand
Short Term Debt 55.89 Million 95 Million 35 Million 25 Million 5 Million 20 Million
Deferred Revenue 380.16 Million 6.71 Million 272.16 Million 181.66 Million 105.99 Million 355.67 Thousand
Other Current Liabilities 108.65 Thousand 342.83 Million 224.9 Thousand 76.8 Thousand 13.44 Million 58.52 Million
Total Non Current Liabilities 205.62 Million 61.79 Million 25.55 Million 24.45 Million 9.2 Million 2.67 Million
Long-Term Debt 181.71 Million 39.03 Million 3.25 Million 2.48 Million 4.85 Million -
Deferred Revenue Non Current 19.97 Million 20.11 Million 18.67 Million 19.13 Million 2.06 Million 1.53 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.21 Million 86.67 Thousand 1.33 Million 5.32 Million 7.13 Million 1.13 Million
Other Liabilities 0.00 - 1.00 1.00 - -
Total Equity 930.76 Million 891.84 Million 844.65 Million 376.97 Million 340.83 Million 194.48 Million
Stock Holders Equity 916.9 Million 881.62 Million 844.65 Million 376.97 Million 340.83 Million 194.48 Million
Common Stock 406.15 Million 405.26 Million 405.26 Million 364.73 Million 364.73 Million 205.68 Million
Retained Earnings -95.65 Million -107.25 Million -131.16 Million -239.13 Million -275.26 Million -244.22 Million
Accumulated other comprehensive income - 6.51 Million 887.36 Thousand 251.36 Million 251.36 Million 233.02 Million
Common Stock Equity 916.9 Million 881.62 Million 844.65 Million 376.97 Million 340.83 Million 194.48 Million
Capital Lease Obligation 4.42 Million 9.04 Million 3.25 Million 2.48 Million 5.53 Million 675.97 Thousand
Total Investments 100.00 90 Million 200 Million 10 Million - 724.91 Thousand
Total Debt 237.6 Million 134.03 Million 38.25 Million 25 Million 5 Million 20 Million
Net Debt -124.46 Million -135.19 Million -216.11 Million -78.98 Million -90.61 Million 8.53 Million

Balance Sheet Charts